在表达CEA的肿瘤模型中使用SPECT/荧光双模态成像检测微转移灶
本研究在小鼠肺内诱导表达CEA的GW-39人结肠癌微集落,静脉注射111In-DTPA-拉贝珠单抗-IRDye800CW后行SPECT与荧光双模态成像,结果显示自肿瘤生长第1周起即可检出亚毫米级肺肿瘤集落,早于肉眼可见,并可引导手术切除。
要点
- 111In-DTPA-拉贝珠单抗-IRDye800CW双模态成像可在肿瘤生长第1周检出亚毫米级肺肿瘤集落。
- 双模态成像可引导肿瘤切除,肿瘤内平均摄取第3周为17.2 ± 5.4、第4周为16.5 ± 4.4(%ID/g)。
- 放射性信号与荧光信号分布与表达CEA的肿瘤共定位。
核心结论
- 注射111In-拉贝珠单抗-IRDye800CW后行双模态成像可在肺肿瘤肉眼可见之前检出亚毫米级表达CEA的肺肿瘤,支持该技术在切除小肿瘤中的附加价值。
研究设计与样本
- 通过静脉注射100 μL GW-39细胞悬液在无胸腺BALB/c小鼠中诱导肺GW-39人结肠癌微集落。
- 在肿瘤生长1、2、3、4周后,于静脉注射111In-DTPA-拉贝珠单抗-IRDye800CW(10 μg,25 MBq)3天后行双模态成像。
- 采集小动物SPECT图像和光学图像并行图像引导手术,最后测定双标记示踪剂的生物分布。
- 对肺组织福尔马林固定切片行荧光成像、放射自显影和免疫组织化学分析。
主要发现
- 自肿瘤生长第1周起,小动物SPECT和荧光成像均可显示亚毫米级肺肿瘤集落,早于肉眼可见。
- 双模态成像可用于引导肿瘤切除。
- 双标记示踪剂在肿瘤中的平均摄取(每克注射剂量百分比)第3周为17.2 ± 5.4、第4周为16.5 ± 4.4。
- 肿瘤肺的免疫组织化学分析显示放射性信号和荧光信号的分布与表达CEA的肿瘤共定位。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intraoperative dual-modality imaging can help the surgeon distinguish tumor from normal tissue. This technique may prove particularly valuable if small tumors need to be removed that are difficult to detect with the naked eye. The humanized anticarcinoembryonic antigen (anti-CEA) monoclonal antibody, labetuzumab, can be used as a tumor-targeting agent in colorectal cancer, since CEA is overexpressed in approximately 95% of colorectal cancer. Dual-labeled labetuzumab, labeled with both a near-infrared fluorescent dye (IRDye800CW) and a radioactive label (111In), can be used as a tracer for dual-modality imaging. This study aimed to assess whether dual-modality imaging using 111In-diethylenetriaminepentaacetic acid (DTPA)-labetuzumab-IRDye800CW can detect pulmonary micrometastases in a mouse model. Methods: Pulmonary GW-39 human colonic carcinoma microcolonies were induced in athymic BALB/c mice by intravenous injection of 100 μL of a GW-39 cell suspension. After 1, 2, 3, and 4 wk of tumor growth, dual-modality imaging was performed 3 d after intravenous injection of 111In-DTPA-labetuzumab-IRDye800CW (10 μg, 25 MBq). Small-animal SPECT images and optical images were acquired, and image-guided surgery was performed. Finally, the biodistribution of the dual-labeled tracer was determined. Formalin-fixed sections of the lungs were analyzed using fluorescence imaging, autoradiography, and immunohistochemistry. Results: Submillimeter pulmonary tumor colonies could be visualized with both small-animal SPECT and fluorescence imaging from the first week of tumor growth, before they became visible to the naked eye. Furthermore, dual-modality imaging could be used to guide resection of tumors. Mean uptake (percentage injected dose per gram) of the dual-labeled tracer in tumors was 17.2 ± 5.4 and 16.5 ± 4.4 at weeks 3 and 4, respectively. Immunohistochemical analysis of the tumorous lungs showed that the distribution of the radioactive and fluorescent signal colocalized with CEA-expressing tumors. Conclusion: Dual-modality imaging after injection of 111In-labetuzumab-IRDye800CW can be used to detect submillimeter CEA-expressing pulmonary tumors before they become visible to the naked eye, supporting the added value of this technique in the resection of small tumors.
引用
- Hekman MCH, Rijpkema M, Bos DL, et al. Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model. J Nucl Med. 2017. PMID: 28126888. doi:10.2967/jnumed.116.185470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。